TotalMarketCap

Prelude Therapeutics

PRLDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$283.701 M

$3.56 -12.87%

Close of 6 Nov 2026

As of 6 Nov 2026, Prelude Therapeutics (PRLD) has a market capitalization of $283.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$12.1M

#3096 by revenue

Earnings

-$99.5M

Loss-making

Shares outstanding

79,803,485

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #219Emergent BioSolutionsEBS$300.0M
  2. #220Enanta PharmaceuticalsENTA$294.2M
  3. #221Prelude TherapeuticsPRLD$283.7M
  4. #222Fulcrum TherapeuticsFULC$281.5M
  5. #223VogenxVOGX$273.8M

What if Prelude Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$353,830.08

Per share 99,530× higher

Bitcoin $1.53T

$19,145.13

Per share 5,385× higher

Apple $5.02T

$62,851.67

Per share 17,680× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Prelude Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.